VRTX — Vertex Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual balance sheet for Vertex Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6,659	7,525	10,779	11,218	6,116
Net Total Accounts Receivable
Net Total Receivables	885	1,137	1,442	1,563	1,609
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	8,133	9,561	13,235	14,144	9,596
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,284	1,424	1,456	1,453	2,585
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	11,752	13,433	18,151	22,730	22,533
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,878	2,142	2,742	3,547	3,565
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3,065	3,333	4,238	5,150	6,124
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	8,687	10,100	13,913	17,580	16,410
Total Liabilities & Shareholders' Equity	11,752	13,433	18,151	22,730	22,533
Total Common Shares Outstanding